article thumbnail

Eco-friendly enzyme to create key chemical building blocks

Science Daily: Pharmacology News

Applying this photoenzymatic approach, researchers have developed a clean, efficient way to synthesize crucial chemical building blocks known as chiral amines, solving a longstanding challenge in synthetic chemistry.

article thumbnail

Women in Stem with Dr Mrunal Jaywant

Drug Target Review

Could you share an example of a specific project or research that you have worked on and the impact it has had in your field? How has your research in STEM contributed to advancements or improvements in your field, and what potential future applications or implications do you foresee based on your work?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Enthera Pharmaceuticals Appoints Kazumi Shiosaki to Its Board of Directors and Lisa Olson to Its Scientific Advisory Board to Push Forward Company Growth and Development

The Pharma Data

Lisa is a senior pharmaceutical executive with more than 20 years of experience in research and drug discovery. She is currently Chief Scientific Officer and Head of Research at Magenta Therapeutics, where she provides strategic direction, oversight and execution for research and discovery efforts.

article thumbnail

BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies

The Pharma Data

About Eurofins Discovery: Eurofins Discovery, a business operating under the Eurofins BioPharma Services division, has supported drug discovery research for over 40 years. In addition to in-vitro safety pharmacology strengths, Eurofins Discovery also offer a broad portfolio of over 3500 drug discovery services and 1800 products.

FDA 52
article thumbnail

Following our pole star to a transformative collaboration

Dark Matter Blog

Roche is one of the strongest research and development organizations in our industry and they share our vision for dramatically expanding access to new molecular targets by developing drugs targeted directly at RNA. Our Chinese CROs are back online and doing synthetic chemistry at a pre-pandemic pace.

RNA 52
article thumbnail

AWS helps Pfizer accelerate drug development and clinical manufacturing

The Pharma Data

Working closely with AWS experts in machine learning and analytics, we aim to provide our scientists and researchers with the insights they need to help deliver medical breakthroughs that change patients’ lives,” said Andrew McKillop, Vice President of Pharmaceutical Sciences, Worldwide Research, Development, and Medical at Pfizer.

article thumbnail

Highlights from SLAS 2022 Conference - Event Recap

The Strateos Blog: Drug Discovery

The focus of this year’s SLAS 2022 was to accelerate life sciences research through the adoption and integration of transformative lab automation technologies. The consensus among the panel is that life science research is evolving from a process-driven approach to a data-driven one. Here are some highlights from SLAS 2022.